News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: genisi post# 90718

Thursday, 12/09/2010 4:26:08 AM

Thursday, December 09, 2010 4:26:08 AM

Post# of 257253
The GALA study of thrice-weekly Copaxone is now enrolling patients; top-line results are expected in Nov 2012:

http://clinicaltrials.gov/ct2/show/NCT01067521

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now